The latest board meeting for Myriad Genetics Inc took place on 10 Mar 2026, for the purpose of Leerink Partners Global Healthcare ConferenceSee details
Myriad Genetics Inc has a share price target of US$ 8, revenue growth forecast of 5.0%, and profit growth estimate of 81.4% for FY26, based on top 12 analyst calls.